First-in-Human Study of Orally Administered GS-441524 for COVID-19

NCT04859244 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
1
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Copycat Sciences LLC